C V A Wynter1, M D Walsh, T Higuchi, B A Leggett, J Young, J R Jass. 1. Conjoint Gastroenterology Laboratory, Royal Brisbane and Women's Hospital Research Foundation, Bancroft Centre, Queensland, Australia. c.wynter@mailbox.uq.edu.au
Abstract
AIM: Hyperplastic polyps (HP) of the colorectum have traditionally been regarded as non-neoplastic lesions. Recent data implicate HP in the pathogenesis of colorectal cancers (CRC) characterised by extensive DNA methylation and microsatellite instability. The aim of this study was to identify morphological and molecular features that may characterise subtypes of HP with potential for neoplastic progression. MATERIALS AND METHODS: HP (22) clustering around distal CRC (group I) were compared with HP (58) in subjects with hyperplastic polyposis (group II). DNA methylation was tested in methylated in tumour (MINT) loci (1, 2, 12, 31) and genes HPP1, MGMT, p14ARF, p16INK4a, and hMLH1. RESULTS: Group II HP showed significantly more methylation than group I HP at all loci except MINT1 and MGMT. Group I showed the lowest frequency of DNA methylation but the highest frequency of K-ras mutation. Group II HP (termed HP variant) had the morphological features of the recently described "sessile serrated adenomas". Methylation of hMLH1 was found most frequently in group II polyps that included foci of dysplasia (7/10) and in no group I lesions. CONCLUSION: The findings support the existence of morphological and molecular heterogeneity among HP and highlight a subset that is likely to have significant malignant potential.
AIM: Hyperplastic polyps (HP) of the colorectum have traditionally been regarded as non-neoplastic lesions. Recent data implicate HP in the pathogenesis of colorectal cancers (CRC) characterised by extensive DNA methylation and microsatellite instability. The aim of this study was to identify morphological and molecular features that may characterise subtypes of HP with potential for neoplastic progression. MATERIALS AND METHODS: HP (22) clustering around distal CRC (group I) were compared with HP (58) in subjects with hyperplastic polyposis (group II). DNA methylation was tested in methylated in tumour (MINT) loci (1, 2, 12, 31) and genes HPP1, MGMT, p14ARF, p16INK4a, and hMLH1. RESULTS: Group II HP showed significantly more methylation than group I HP at all loci except MINT1 and MGMT. Group I showed the lowest frequency of DNA methylation but the highest frequency of K-ras mutation. Group II HP (termed HP variant) had the morphological features of the recently described "sessile serrated adenomas". Methylation of hMLH1 was found most frequently in group II polyps that included foci of dysplasia (7/10) and in no group I lesions. CONCLUSION: The findings support the existence of morphological and molecular heterogeneity among HP and highlight a subset that is likely to have significant malignant potential.
Authors: Vicki L J Whitehall; Coral V A Wynter; Michael D Walsh; Lisa A Simms; David Purdie; Nirmala Pandeya; Joanne Young; Stephen J Meltzer; Barbara A Leggett; Jeremy R Jass Journal: Cancer Res Date: 2002-11-01 Impact factor: 12.701
Authors: Annie On-On Chan; Russell R Broaddus; Patrick S Houlihan; Jean-Pierre J Issa; Stanley R Hamilton; Asif Rashid Journal: Am J Pathol Date: 2002-05 Impact factor: 4.307
Authors: W S Samowitz; J A Holden; K Curtin; S L Edwards; A R Walker; H A Lin; M A Robertson; M F Nichols; K M Gruenthal; B J Lynch; M F Leppert; M L Slattery Journal: Am J Pathol Date: 2001-04 Impact factor: 4.307
Authors: J Young; K G Biden; L A Simms; P Huggard; R Karamatic; H J Eyre; G R Sutherland; N Herath; M Barker; G J Anderson; D R Fitzpatrick; G A Ramm; J R Jass; B A Leggett Journal: Proc Natl Acad Sci U S A Date: 2001-01-02 Impact factor: 11.205
Authors: Tian Rui Chen; Ping Wang; Liberty K Carroll; Ying-jiu Zhang; Bao-Xia Han; Fan Wang Journal: Biochem Biophys Res Commun Date: 2012-07-22 Impact factor: 3.575
Authors: Babar Bashir; Dante J Merlino; Jeffrey A Rappaport; Esteban Gnass; Juan P Palazzo; Ying Feng; Eric R Fearon; Adam E Snook; Scott A Waldman Journal: Hum Pathol Date: 2019-02-02 Impact factor: 3.466
Authors: Árpád V Patai; Barbara Kinga Barták; Bálint Péterfia; Tamás Micsik; Réka Horváth; Csaba Sumánszki; Zoltán Péter; Árpád Patai; Gábor Valcz; Alexandra Kalmár; Kinga Tóth; Tibor Krenács; Zsolt Tulassay; Béla Molnár Journal: Pathol Oncol Res Date: 2016-11-29 Impact factor: 3.201
Authors: Robyn Beach; Annie On-On Chan; Tsung-Teh Wu; Jill A White; Jeffrey S Morris; Simon Lunagomez; Russell R Broaddus; Jean-Pierre J Issa; Stanley R Hamilton; Asif Rashid Journal: Am J Pathol Date: 2005-04 Impact factor: 4.307
Authors: T Kambara; L A Simms; V L J Whitehall; K J Spring; C V A Wynter; M D Walsh; M A Barker; S Arnold; A McGivern; N Matsubara; N Tanaka; T Higuchi; J Young; J R Jass; B A Leggett Journal: Gut Date: 2004-08 Impact factor: 23.059